As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, discusses how growing FDA support is accelerating the adoption of Bayesian approaches, enabling more flexible, ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Bayesian inference has been used for genetic risk calculation. In this traditional method, inheritance events are divided into a number of cases under the inheritance model, and some elements of the ...

Scientists have developed a method to identify symmetries in multi-dimensional data using Bayesian statistical techniques. Bayesian statistics has been in the spotlight in recent years due to ...